Financial statements Nanosanguis
Balance sheet data of NANOSANGUIS
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 5 251 768,98 | 7 237 511,58 | 8 504 311,18 | 4 688 144,24 | 8 448 665,02 | 8 145 002,59 |
| A. Fixed assets | 4 881 960,42 | 6 546 169,61 | 8 347 315,68 | 3 790 880,74 | 7 613 534,40 | 7 718 320,17 |
| B. Current assets | 369 808,56 | 691 341,97 | 156 995,50 | 864 063,50 | 835 130,62 | 426 682,42 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 33 200,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 5 251 768,98 | 7 237 511,58 | 8 504 311,18 | 4 688 144,24 | 8 448 665,02 | 8 145 002,59 |
| A. Equity | 2 113 487,19 | 2 080 421,81 | 2 526 195,25 | -1 319 341,16 | 2 024 216,73 | 3 603 805,10 |
| B. Liabilities and provisions for liabilities | 3 138 281,79 | 5 157 089,77 | 5 978 115,93 | 6 007 485,40 | 6 424 448,29 | 4 541 197,49 |
| I. Long-term liabilities | 0,00 | 778 007,78 | 833 073,12 | 889 899,51 | 946 725,90 | 1 003 552,29 |
| II. Short-term liabilities | 134 852,81 | 62 524,60 | 212 388,09 | 95 623,69 | 345 184,06 | 630 425,65 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.